MAIA Biotechnology Reports Progress in Cancer Drug Development
PremiumCompany AnnouncementsMAIA Biotechnology Reports Progress in Cancer Drug Development
5M ago
MAIA reports THIO-101 data from third-line treatment shows ORR of 38%
Premium
The Fly
MAIA reports THIO-101 data from third-line treatment shows ORR of 38%
5M ago
MAIA Biotechnology Highlights Clinical Progress and Investor Insights
Premium
Company Announcements
MAIA Biotechnology Highlights Clinical Progress and Investor Insights
5M ago
MAIA Biotechnology director purchases 147,492 shares in private placement
PremiumThe FlyMAIA Biotechnology director purchases 147,492 shares in private placement
6M ago
MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary
Premium
Company Announcements
MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary
7M ago
MAIA Biotechnology to sell 578,643 shares at $2.295 in private placement
Premium
The Fly
MAIA Biotechnology to sell 578,643 shares at $2.295 in private placement
8M ago
Maia Biotechnology Inc trading halted, news pending
PremiumThe FlyMaia Biotechnology Inc trading halted, news pending
8M ago
MAIA Biotechnology announces efficacy data for THIO-101 clinical trial
Premium
The Fly
MAIA Biotechnology announces efficacy data for THIO-101 clinical trial
8M ago
MAIA Biotechnology Advances with Phase 2 Lung Cancer Trial
Premium
Company Announcements
MAIA Biotechnology Advances with Phase 2 Lung Cancer Trial
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100